Basic Materials [ 9/13 ] | Specialty Chemicals [ 86/159 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 23 | -0.02 Decreased by -266.04% | - |
| Jun 30, 23 | -0.02 Decreased by -84.54% | - |
| Mar 31, 23 | -0 Decreased by -500% | - |
| Dec 31, 22 | -0.01 Decreased by -271.43% | - |
| Sep 30, 22 | -0.01 Decreased by -125.6% | - |
| Jun 30, 22 | -0.01 Decreased by -670.59% | - |
| Mar 31, 22 | 0 Increased by +500% | - |
| Dec 31, 21 | 0.01 Increased by +215% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 2.55 M Decreased by -0.83% | -2.61 M Decreased by -3.27 K% | Decreased by -102.13% Decreased by -3.3 K% |
| Jun 30, 23 | 2.57 M Increased by +3.29% | -259.25 K Decreased by -86.97% | Decreased by -10.1% Decreased by -81.01% |
| Mar 31, 23 | 2.38 M Decreased by -26.75% | -69.07 K Decreased by -177.39% | Decreased by -2.91% Decreased by -205.65% |
| Dec 31, 22 | 2.84 M Decreased by -12.5% | -156.97 K Decreased by -275.89% | Decreased by -5.53% Decreased by -301.02% |
| Sep 30, 22 | 2.58 M Decreased by -27.99% | -77.4 K Decreased by -126.21% | Decreased by -3.01% Decreased by -136.4% |
| Jun 30, 22 | 2.49 M Decreased by -19.63% | -138.66 K Decreased by -590.63% | Decreased by -5.58% Decreased by -710.48% |
| Mar 31, 22 | 3.25 M Decreased by -5.91% | 89.24 K Decreased by -73.65% | Increased by +2.75% Decreased by -72% |
| Dec 31, 21 | 3.25 M Decreased by -71.43% | 89.24 K Decreased by -92.97% | Increased by +2.75% Decreased by -75.37% |
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.